HFA Premium Access

Brain natriuretic peptide level in patients with hypertrophic cardiomyopathy

Congress Presentation

About the speaker

Mrs Alexandra Demkina

Scientific and Practical Clinical Center for Diagnostics and Telemedicine, Moscow (Russian Federation)
0 follower

5 more presentations in this session

Predictors of ICD-related adverse events in patients with hypertrophic cardiomyopathy

Speaker: Mr C. Klein (Lille, FR)

Thumbnail

Impact of hypertrophy in left ventricular ejection fraction and myocardial strain: application of three-dimensional wall-motion tracking technology in hypertrophic cardiomyopathy

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Thumbnail

Assessment of left ventricular strain by three-dimensional wall-motion tracking technology: a study in hypertrophic cardiomyopathy

Speaker: Doctor L. Marques (Sra. da Hora, PT)

Thumbnail

Myosin heavy chain and MAP-kinase activating death domain-containing gene polymorphisms in adults with hypertrophic cardiomyopathy

Speaker: Miss A. Polyakova (Saint Petersburg, RU)

Thumbnail

The role of soluble st2 and galectin-3 in hypertrophic cardiomyopathy assessed by cardiac magnetic resonance

Speaker: Doctor M. Gawor (Warsaw, PL)

Thumbnail

Access the full session

Poster Session 4 - Hypertrophic cardiomyopathy

Speakers: Mrs A. Demkina, Mr C. Klein, Doctor L. Marques, Doctor L. Marques, Miss A. Polyakova...
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb